rivaroxaban clonmel 15 mg hard capsules rivaroxaban clonmel 20 mg hard capsules
clonmel healthcare ltd - rivaroxaban; rivaroxaban - capsule, hard - rivaroxaban
rivaroxaban pharos 15mg / rivaroxaban pharos 20mg film-coated tablets
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 15 mg rivaroxaban 20 mg - antithrombotic agents
rivaroxaban clonmel 15 mg film-coated tablets rivaroxaban clonmel 20 mg film-coated tablets
clonmel healthcare ltd - rivaroxaban; rivaroxaban - film-coated tablet - rivaroxaban
reddy-rivaroxaban tablet
dr reddy's laboratories ltd - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg
taro-rivaroxaban tablet
taro pharmaceuticals inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg
apo-rivaroxaban tablet
apotex inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg
apo-rivaroxaban tablet
apotex inc - rivaroxaban - tablet - 15mg - rivaroxaban 15mg
reddy-rivaroxaban tablet
dr reddy's laboratories ltd - rivaroxaban - tablet - 15mg - rivaroxaban 15mg
taro-rivaroxaban tablet
taro pharmaceuticals inc - rivaroxaban - tablet - 15mg - rivaroxaban 15mg
apo-rivaroxaban rivaroxaban 15 mg tablet blister pack
arrotex pharmaceuticals pty ltd - rivaroxaban, quantity: 15 mg - tablet - excipient ingredients: lactose; poloxamer; silicon dioxide; croscarmellose sodium; purified talc; polyvinyl alcohol; iron oxide red; macrogol 8000; magnesium stearate; titanium dioxide - prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.